Biocatalysis: Synthesis of Key Intermediates for Development of Pharmaceuticals
- 9 August 2011
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 1 (9) , 1056-1074
- https://doi.org/10.1021/cs200219b
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- BIOCATALYSIS HELPS REACH A RESOLUTIONChemical & Engineering News, 2006
- Creation of a Broad-Range and Highly Stereoselectived-Amino Acid Dehydrogenase for the One-Step Synthesis ofd-Amino AcidsJournal of the American Chemical Society, 2006
- Biocatalytic ammonolysis of (5S)-4,5-dihydro-1H-pyrrole-1,5-dicarboxylic acid, 1-(1,1-dimethylethyl)-5-ethyl ester: Preparation of an intermediate to the dipeptidyl peptidase IV inhibitor SaxagliptinBioorganic & Medicinal Chemistry Letters, 2006
- Highly Selective Asymmetric Hydrogenation Using a Three Hindered Quadrant Bisphosphine Rhodium CatalystJournal of the American Chemical Society, 2004
- CRF1receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndromeBritish Journal of Pharmacology, 2004
- Process Development on the Enantioselective Enzymatic Hydrolysis of S-Ethyl 2-Ethoxy-3-(4-hydroxyphenyl)propanoateOrganic Process Research & Development, 2002
- Development of a Continuous Enzymatic Process for the Preparation of (R)-3-(4-Fluorophenyl)-2-hydroxy Propionic AcidOrganic Process Research & Development, 2002
- Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.The American Journal of Cardiology, 2001
- Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P1 Lactam Moieties as l-Glutamine ReplacementsJournal of Medicinal Chemistry, 1999
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993